Christopher Joseph Miller, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mental Health Services | 23 | 2024 | 1731 | 4.220 |
Why?
|
United States Department of Veterans Affairs | 30 | 2025 | 940 | 3.690 |
Why?
|
Mohs Surgery | 13 | 2021 | 217 | 2.160 |
Why?
|
Veterans | 20 | 2024 | 2671 | 1.940 |
Why?
|
Telemedicine | 11 | 2024 | 3107 | 1.590 |
Why?
|
Patient Care Team | 11 | 2023 | 2529 | 1.490 |
Why?
|
Skin Neoplasms | 14 | 2022 | 5857 | 1.380 |
Why?
|
MART-1 Antigen | 2 | 2020 | 62 | 1.320 |
Why?
|
Qualitative Research | 13 | 2024 | 3131 | 1.300 |
Why?
|
Bipolar Disorder | 15 | 2025 | 5126 | 1.250 |
Why?
|
Wound Closure Techniques | 2 | 2018 | 88 | 1.170 |
Why?
|
Evidence-Based Practice | 3 | 2021 | 500 | 1.150 |
Why?
|
Mental Health | 15 | 2024 | 3276 | 1.040 |
Why?
|
Primary Health Care | 9 | 2024 | 4748 | 0.920 |
Why?
|
Attitude of Health Personnel | 5 | 2024 | 3922 | 0.870 |
Why?
|
Melanoma | 6 | 2020 | 5705 | 0.740 |
Why?
|
Outpatients | 4 | 2024 | 1604 | 0.740 |
Why?
|
Clinical Coding | 2 | 2019 | 186 | 0.680 |
Why?
|
Hyperphosphatemia | 1 | 2018 | 38 | 0.590 |
Why?
|
Facial Neoplasms | 1 | 2018 | 126 | 0.580 |
Why?
|
Quality of Health Care | 4 | 2024 | 4339 | 0.570 |
Why?
|
Rural Health Services | 1 | 2021 | 393 | 0.570 |
Why?
|
Models, Organizational | 4 | 2020 | 548 | 0.550 |
Why?
|
Carcinoma, Basal Cell | 2 | 2020 | 562 | 0.550 |
Why?
|
Delivery of Health Care | 7 | 2023 | 5375 | 0.540 |
Why?
|
Mass Screening | 2 | 2024 | 5451 | 0.530 |
Why?
|
Stress Disorders, Post-Traumatic | 8 | 2024 | 4641 | 0.530 |
Why?
|
Mental Disorders | 10 | 2023 | 6876 | 0.520 |
Why?
|
Melanocytes | 2 | 2018 | 508 | 0.500 |
Why?
|
Health Services Research | 4 | 2020 | 1817 | 0.500 |
Why?
|
Interprofessional Relations | 3 | 2018 | 997 | 0.500 |
Why?
|
Epidermis | 1 | 2018 | 539 | 0.490 |
Why?
|
Antimanic Agents | 2 | 2016 | 524 | 0.490 |
Why?
|
Antipsychotic Agents | 4 | 2016 | 3080 | 0.490 |
Why?
|
United States | 40 | 2025 | 73150 | 0.490 |
Why?
|
Health Services Accessibility | 7 | 2024 | 5512 | 0.470 |
Why?
|
Cooperative Behavior | 7 | 2024 | 1515 | 0.460 |
Why?
|
Phosphates | 1 | 2018 | 765 | 0.460 |
Why?
|
Long-Term Care | 4 | 2024 | 632 | 0.450 |
Why?
|
Continuity of Patient Care | 1 | 2021 | 1076 | 0.450 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9433 | 0.440 |
Why?
|
Videoconferencing | 3 | 2023 | 209 | 0.440 |
Why?
|
Surgical Flaps | 3 | 2018 | 1682 | 0.440 |
Why?
|
Behavioral Research | 1 | 2013 | 52 | 0.440 |
Why?
|
Computers | 1 | 2016 | 592 | 0.430 |
Why?
|
Health Education | 1 | 2020 | 1057 | 0.430 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2017 | 330 | 0.430 |
Why?
|
Patient Preference | 2 | 2021 | 947 | 0.410 |
Why?
|
Community Mental Health Centers | 1 | 2012 | 93 | 0.410 |
Why?
|
Humans | 91 | 2025 | 768393 | 0.400 |
Why?
|
Antibiotic Prophylaxis | 3 | 2021 | 640 | 0.380 |
Why?
|
Precancerous Conditions | 1 | 2018 | 984 | 0.370 |
Why?
|
Shock, Septic | 1 | 2018 | 774 | 0.370 |
Why?
|
Patient Acceptance of Health Care | 3 | 2022 | 3231 | 0.370 |
Why?
|
Evidence-Based Medicine | 4 | 2025 | 3707 | 0.370 |
Why?
|
Telephone | 2 | 2024 | 630 | 0.350 |
Why?
|
Health Personnel | 2 | 2023 | 3380 | 0.350 |
Why?
|
Psychotherapy | 1 | 2019 | 1656 | 0.340 |
Why?
|
Hand | 3 | 2021 | 912 | 0.330 |
Why?
|
Head and Neck Neoplasms | 3 | 2022 | 2923 | 0.330 |
Why?
|
Patient-Centered Care | 2 | 2019 | 1447 | 0.330 |
Why?
|
Research Design | 3 | 2020 | 6210 | 0.320 |
Why?
|
Ambulatory Care Facilities | 5 | 2022 | 941 | 0.320 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10377 | 0.320 |
Why?
|
Neoplasm, Residual | 3 | 2020 | 1019 | 0.310 |
Why?
|
Pandemics | 7 | 2024 | 8753 | 0.310 |
Why?
|
Hutchinson's Melanotic Freckle | 2 | 2018 | 26 | 0.290 |
Why?
|
Patient Selection | 2 | 2017 | 4266 | 0.290 |
Why?
|
Program Evaluation | 5 | 2024 | 2505 | 0.280 |
Why?
|
Female | 50 | 2024 | 397089 | 0.270 |
Why?
|
Respiration, Artificial | 1 | 2018 | 2721 | 0.270 |
Why?
|
Decision Making | 2 | 2020 | 3953 | 0.270 |
Why?
|
Organizational Culture | 2 | 2021 | 512 | 0.270 |
Why?
|
Middle Aged | 39 | 2024 | 223491 | 0.260 |
Why?
|
Male | 47 | 2024 | 364902 | 0.260 |
Why?
|
United States Department of Defense | 1 | 2025 | 36 | 0.240 |
Why?
|
Adult | 36 | 2024 | 223640 | 0.240 |
Why?
|
Aged, 80 and over | 14 | 2022 | 59686 | 0.230 |
Why?
|
Sepsis | 1 | 2018 | 2601 | 0.220 |
Why?
|
Biomedical Research | 1 | 2019 | 3464 | 0.220 |
Why?
|
Skin | 1 | 2017 | 4499 | 0.220 |
Why?
|
Vagus Nerve | 2 | 2017 | 460 | 0.210 |
Why?
|
Quality of Life | 6 | 2024 | 13503 | 0.210 |
Why?
|
Aged | 26 | 2024 | 171562 | 0.210 |
Why?
|
Personality | 1 | 2006 | 560 | 0.210 |
Why?
|
Neoplasm Invasiveness | 3 | 2020 | 3633 | 0.200 |
Why?
|
Chronic Disease | 4 | 2021 | 9379 | 0.200 |
Why?
|
Leg | 2 | 2017 | 1088 | 0.200 |
Why?
|
Surgical Wound Infection | 2 | 2021 | 1545 | 0.190 |
Why?
|
Serotonin | 1 | 2006 | 1045 | 0.190 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10267 | 0.180 |
Why?
|
Psychometrics | 3 | 2019 | 3069 | 0.180 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 26375 | 0.170 |
Why?
|
Hydroxyl Radical | 1 | 2020 | 82 | 0.170 |
Why?
|
Young Adult | 11 | 2021 | 60049 | 0.170 |
Why?
|
Oxidants | 1 | 2020 | 168 | 0.160 |
Why?
|
Postoperative Complications | 2 | 2018 | 15881 | 0.160 |
Why?
|
Biopsy | 4 | 2019 | 6808 | 0.160 |
Why?
|
Control Groups | 1 | 2019 | 107 | 0.160 |
Why?
|
Interviews as Topic | 2 | 2024 | 2740 | 0.160 |
Why?
|
Scalp | 1 | 2022 | 391 | 0.160 |
Why?
|
Organizational Policy | 1 | 2021 | 434 | 0.160 |
Why?
|
Goals | 1 | 2024 | 716 | 0.160 |
Why?
|
Self Report | 3 | 2019 | 3766 | 0.150 |
Why?
|
Forehead | 1 | 2018 | 75 | 0.150 |
Why?
|
Frontal Bone | 1 | 2018 | 106 | 0.150 |
Why?
|
Counseling | 2 | 2024 | 1553 | 0.150 |
Why?
|
Retrospective Studies | 12 | 2022 | 81801 | 0.150 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 123 | 0.150 |
Why?
|
Periosteum | 1 | 2018 | 139 | 0.150 |
Why?
|
Decision Trees | 1 | 2020 | 509 | 0.150 |
Why?
|
Adolescent | 11 | 2021 | 89184 | 0.150 |
Why?
|
Mentally Ill Persons | 1 | 2018 | 126 | 0.150 |
Why?
|
Empirical Research | 1 | 2018 | 119 | 0.150 |
Why?
|
Free Tissue Flaps | 1 | 2022 | 337 | 0.140 |
Why?
|
Social Isolation | 1 | 2020 | 369 | 0.140 |
Why?
|
Telecommunications | 1 | 2017 | 79 | 0.140 |
Why?
|
Genitalia | 1 | 2017 | 113 | 0.140 |
Why?
|
Hospitals, Veterans | 1 | 2019 | 395 | 0.140 |
Why?
|
Immunocompetence | 1 | 2017 | 138 | 0.140 |
Why?
|
Anxiety Disorders | 2 | 2019 | 2754 | 0.130 |
Why?
|
Duodenum | 1 | 2019 | 495 | 0.130 |
Why?
|
Autonomic Nerve Block | 1 | 2017 | 82 | 0.130 |
Why?
|
Professional Role | 1 | 2019 | 316 | 0.130 |
Why?
|
Health Facilities | 1 | 2021 | 577 | 0.130 |
Why?
|
Skin Transplantation | 2 | 2018 | 1097 | 0.130 |
Why?
|
Toes | 1 | 2017 | 209 | 0.130 |
Why?
|
Leadership | 2 | 2023 | 1395 | 0.130 |
Why?
|
Foot Diseases | 1 | 2017 | 148 | 0.130 |
Why?
|
Depression | 4 | 2019 | 8241 | 0.130 |
Why?
|
Perception | 2 | 2019 | 1205 | 0.120 |
Why?
|
Medication Therapy Management | 1 | 2016 | 131 | 0.120 |
Why?
|
Health Services | 1 | 2020 | 756 | 0.120 |
Why?
|
Obesity, Morbid | 2 | 2017 | 1309 | 0.120 |
Why?
|
Rectum | 1 | 2019 | 902 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1669 | 0.120 |
Why?
|
Vascular Diseases | 1 | 2023 | 1161 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2337 | 0.120 |
Why?
|
Tendons | 1 | 2018 | 559 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1727 | 0.110 |
Why?
|
Waiting Lists | 1 | 2019 | 780 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2018 | 647 | 0.110 |
Why?
|
Fingers | 1 | 2017 | 512 | 0.110 |
Why?
|
Dermatofibrosarcoma | 1 | 2014 | 49 | 0.110 |
Why?
|
Hospitalization | 4 | 2021 | 10844 | 0.110 |
Why?
|
Physicians, Primary Care | 2 | 2017 | 623 | 0.110 |
Why?
|
Community Mental Health Services | 2 | 2013 | 388 | 0.110 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 568 | 0.110 |
Why?
|
Foot | 1 | 2017 | 577 | 0.110 |
Why?
|
Vagus Nerve Stimulation | 1 | 2017 | 229 | 0.110 |
Why?
|
Extremities | 1 | 2018 | 870 | 0.110 |
Why?
|
Psychiatry | 2 | 2023 | 1715 | 0.110 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11254 | 0.100 |
Why?
|
Reminder Systems | 1 | 2016 | 387 | 0.100 |
Why?
|
Electrodes, Implanted | 1 | 2017 | 841 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2023 | 65379 | 0.100 |
Why?
|
Comparative Effectiveness Research | 2 | 2016 | 713 | 0.100 |
Why?
|
Clinical Competence | 2 | 2019 | 4848 | 0.100 |
Why?
|
Organ Specificity | 1 | 2017 | 1967 | 0.100 |
Why?
|
Hair Follicle | 1 | 2014 | 219 | 0.100 |
Why?
|
Practice Guidelines as Topic | 3 | 2025 | 7453 | 0.090 |
Why?
|
Linear Models | 2 | 2019 | 5878 | 0.090 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2019 | 6034 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1448 | 0.090 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 368 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1280 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1673 | 0.090 |
Why?
|
Electric Stimulation Therapy | 1 | 2017 | 636 | 0.090 |
Why?
|
Women's Health | 1 | 2020 | 2078 | 0.090 |
Why?
|
Antigens, Neoplasm | 1 | 2018 | 1999 | 0.090 |
Why?
|
Metered Dose Inhalers | 1 | 2010 | 28 | 0.090 |
Why?
|
Ethanolamines | 1 | 2010 | 153 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3579 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2006 | 0.080 |
Why?
|
Budesonide | 1 | 2010 | 162 | 0.080 |
Why?
|
Drug Therapy, Combination | 2 | 2016 | 6318 | 0.080 |
Why?
|
Time Factors | 3 | 2021 | 40272 | 0.080 |
Why?
|
Risk Factors | 8 | 2021 | 74962 | 0.080 |
Why?
|
Nerve Block | 1 | 2015 | 716 | 0.080 |
Why?
|
Alcoholism | 1 | 2018 | 1982 | 0.070 |
Why?
|
Health Care Costs | 1 | 2020 | 3267 | 0.070 |
Why?
|
Weight Loss | 2 | 2017 | 2713 | 0.070 |
Why?
|
Arthritis | 1 | 2012 | 684 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39407 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2122 | 0.070 |
Why?
|
Immunohistochemistry | 1 | 2020 | 11120 | 0.070 |
Why?
|
Bronchodilator Agents | 1 | 2010 | 519 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2021 | 4875 | 0.060 |
Why?
|
Trust | 2 | 2023 | 532 | 0.060 |
Why?
|
Organizational Innovation | 2 | 2020 | 540 | 0.060 |
Why?
|
Receptors, Serotonin | 1 | 2006 | 211 | 0.060 |
Why?
|
Reward | 1 | 2012 | 984 | 0.060 |
Why?
|
Emotions | 2 | 2018 | 2768 | 0.060 |
Why?
|
Harm Reduction | 1 | 2006 | 143 | 0.060 |
Why?
|
Critical Illness | 1 | 2018 | 2755 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4069 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 1407 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18471 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2018 | 3801 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2948 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6350 | 0.060 |
Why?
|
Temperament | 1 | 2006 | 301 | 0.060 |
Why?
|
Impulsive Behavior | 1 | 2006 | 349 | 0.060 |
Why?
|
Internet | 1 | 2016 | 3107 | 0.060 |
Why?
|
Personality Inventory | 1 | 2006 | 1018 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8051 | 0.050 |
Why?
|
Survival Rate | 1 | 2017 | 12870 | 0.050 |
Why?
|
Mesocricetus | 1 | 2023 | 256 | 0.050 |
Why?
|
Cost of Illness | 1 | 2012 | 1959 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4056 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2022 | 286 | 0.050 |
Why?
|
Metacarpal Bones | 1 | 2021 | 77 | 0.040 |
Why?
|
Depressive Disorder, Major | 1 | 2018 | 4819 | 0.040 |
Why?
|
Ferrous Compounds | 1 | 2020 | 41 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 2019 | 114 | 0.040 |
Why?
|
Safety | 1 | 2024 | 1159 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15939 | 0.040 |
Why?
|
Cricetinae | 1 | 2023 | 2423 | 0.040 |
Why?
|
Quality Improvement | 3 | 2019 | 3858 | 0.040 |
Why?
|
Geography | 1 | 2020 | 654 | 0.040 |
Why?
|
Violence | 1 | 2024 | 938 | 0.040 |
Why?
|
Space-Time Clustering | 1 | 2016 | 45 | 0.040 |
Why?
|
Blood | 1 | 2019 | 597 | 0.030 |
Why?
|
Firearms | 1 | 2024 | 632 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2021 | 393 | 0.030 |
Why?
|
Stereotyping | 1 | 2018 | 242 | 0.030 |
Why?
|
Patient Satisfaction | 2 | 2020 | 3486 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1126 | 0.030 |
Why?
|
Internship and Residency | 1 | 2016 | 5949 | 0.030 |
Why?
|
Financing, Personal | 1 | 2018 | 310 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2017 | 12456 | 0.030 |
Why?
|
Schizophrenia | 1 | 2014 | 6987 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2018 | 1004 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2021 | 2931 | 0.030 |
Why?
|
Heartburn | 1 | 2015 | 71 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2019 | 1866 | 0.030 |
Why?
|
Demography | 1 | 2019 | 1642 | 0.030 |
Why?
|
Dyspepsia | 1 | 2015 | 116 | 0.030 |
Why?
|
Community Health Services | 1 | 2019 | 659 | 0.030 |
Why?
|
Valproic Acid | 1 | 2016 | 443 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2225 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2437 | 0.030 |
Why?
|
Lithium | 1 | 2016 | 600 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4039 | 0.030 |
Why?
|
Suicide | 1 | 2024 | 1607 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17575 | 0.030 |
Why?
|
Behavioral Medicine | 1 | 2013 | 49 | 0.030 |
Why?
|
Electrodes | 1 | 2015 | 617 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1298 | 0.030 |
Why?
|
Feedback | 1 | 2016 | 795 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1262 | 0.020 |
Why?
|
Social Behavior | 1 | 2018 | 1146 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2728 | 0.020 |
Why?
|
Anxiety | 1 | 2006 | 4677 | 0.020 |
Why?
|
Iron | 1 | 2020 | 1814 | 0.020 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1903 | 0.020 |
Why?
|
Carcinoma in Situ | 1 | 2016 | 789 | 0.020 |
Why?
|
Asthma | 1 | 2010 | 6280 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15872 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2106 | 0.020 |
Why?
|
Military Personnel | 1 | 2018 | 1266 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2015 | 1070 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5496 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3960 | 0.020 |
Why?
|
Teaching | 1 | 2016 | 1172 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2019 | 3048 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22296 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10117 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2019 | 2784 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1882 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4411 | 0.020 |
Why?
|
Nurses | 1 | 2016 | 2494 | 0.020 |
Why?
|
Health Behavior | 1 | 2018 | 2647 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2010 | 1169 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10654 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1813 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41795 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 1696 | 0.010 |
Why?
|
Anti-Asthmatic Agents | 1 | 2010 | 577 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2016 | 2913 | 0.010 |
Why?
|
Lung | 1 | 2023 | 10089 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18362 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7861 | 0.010 |
Why?
|
Curriculum | 1 | 2016 | 3776 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3912 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4859 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20224 | 0.010 |
Why?
|
Brain | 1 | 2006 | 27454 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10588 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13052 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54920 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24318 | 0.010 |
Why?
|
Animals | 1 | 2023 | 169337 | 0.010 |
Why?
|